Vivo Capital Fund VIII, L.P.

FollowCreate a free account to set a filing alert.

10% owner at TREX WIND-DOWN, INC. · on record since May 1, 2017
10% owner at Yarrow Bioscience, Inc. · on record since Jan 29, 2018
10% owner at Crinetics Pharmaceuticals, Inc. · on record since Jul 20, 2018
10% owner at Kadmon Holdings, Inc. · on record since Jan 8, 2019
10% owner at Aligos Therapeutics, Inc. · on record since Oct 20, 2020
10% owner at Teledyne Bolt, Inc. · on record since Feb 9, 2021
10% owner at Terns Pharmaceuticals, Inc. · on record since Feb 9, 2021
10% owner at IMPERIAL INDUSTRIES INC · on record since Apr 29, 2021

Insider trading activity of Vivo Capital Fund VIII, L.P.

Transactions on record: 40; since May 1, 2017

Purchases: 10; $20.7M

Sales: 7; $4.5M

Companies traded: 4; last filing Feb 9, 2021

Figures computed from official regulatory filings — .

Companies where Vivo Capital Fund VIII, L.P. has traded

Terns Pharmaceuticals, Inc.9 tx · $8.1M · Feb 9, 2021
Crinetics Pharmaceuticals, Inc.19 tx · $11.1M · Apr 7, 2020
Yarrow Bioscience, Inc.10 tx · $5M · Jan 29, 2018
TREX WIND-DOWN, INC.2 tx · $1M · May 1, 2017

Track record of Vivo Capital Fund VIII, L.P.

Statistical track record

Free account

Purchases: 11

Last buy: Feb 9, 2021

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Vivo Capital Fund VIII, L.P.

Co-insiders of Vivo Capital Fund VIII, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-98,484	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Other	266,948	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Buy	357,353	17.00 USD	$6.1M	conv 81ClusterUnusual size+1	SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-713,203	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-364,138	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Buy	103,372	17.00 USD	$1.8M	conv 40ClusterFirst in 12mo	SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-50,282	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Other	1,933,185	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Buy	14,275	17.00 USD	$242.7K	conv 39ClusterFirst in 12mo	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-742	14.20 USD	$10.5K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-5,373	14.20 USD	$76.3K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-263,600	13.80 USD	$3.6M	Unusual size	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-36,400	13.80 USD	$502.3K	Unusual size	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Feb 6, 2020	Sell	-2,584	22.80 USD	$58.9K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Feb 6, 2020	Sell	-357	22.80 USD	$8.1K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Feb 6, 2020	Sell	-10,519	22.80 USD	$239.8K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	OtherD (derivative)	-1,358,903	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Other	2,560,613	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	OtherD (derivative)	-1,163,311	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Other	57,035	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Buy	51,686	17.00 USD	$878.7K	conv 31Cluster	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Buy	153,180	20.73 USD	$3.2M	conv 62Cluster	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Buy	7,137	17.00 USD	$121.3K	conv 31Cluster	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	OtherD (derivative)	-187,648	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Other	413,040	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-98,484	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Other	266,948	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Buy	357,353	17.00 USD	$6.1M	conv 81ClusterUnusual size+1	SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-713,203	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-364,138	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Buy	103,372	17.00 USD	$1.8M	conv 40ClusterFirst in 12mo	SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	OtherD (derivative)	-50,282	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Other	1,933,185	—	n/a (No price was disclosed in the filing)		SEC
Terns Pharmaceuticals, Inc.Listing unverified	Feb 9, 2021	Buy	14,275	17.00 USD	$242.7K	conv 39ClusterFirst in 12mo	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-742	14.20 USD	$10.5K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-5,373	14.20 USD	$76.3K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-263,600	13.80 USD	$3.6M	Unusual size	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Apr 7, 2020	Sell	-36,400	13.80 USD	$502.3K	Unusual size	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Feb 6, 2020	Sell	-2,584	22.80 USD	$58.9K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Feb 6, 2020	Sell	-357	22.80 USD	$8.1K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Feb 6, 2020	Sell	-10,519	22.80 USD	$239.8K		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	OtherD (derivative)	-1,358,903	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Other	2,560,613	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	OtherD (derivative)	-1,163,311	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Other	57,035	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Buy	51,686	17.00 USD	$878.7K	conv 31Cluster	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Buy	153,180	20.73 USD	$3.2M	conv 62Cluster	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Buy	7,137	17.00 USD	$121.3K	conv 31Cluster	SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	OtherD (derivative)	-187,648	—	n/a (No price was disclosed in the filing)		SEC
Crinetics Pharmaceuticals, Inc.Security delisted	Jul 20, 2018	Other	413,040	—	n/a (No price was disclosed in the filing)		SEC